Australian market closed in red with the end of trading session on 23 January 2019. The benchmark index S&P/ASX 200 settled at A$5843.7, down by 15 points. In the light of this, let us look at three stocks that went up on the ASX Ladder today:
BBX Minerals Limited (ASX: BBX)
The small-cap mining company, BBX Minerals Limited recorded more than 21% gains in today’s trading session, opening at 15 cents and finally settling at 17 cents. The price of the scrip is trading on the downside from the past three months falling by almost 26%. The stock has offered a negative YTD return of 20% to its investors this year. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]
BBX Minerals is a mining company engaged in mineral exploration and development with key projects across Brazil and South America. Its projects include the Juma East project, the EMA project, the Ema & Tres Estados project, and the Pombos project. The group posted a Net Loss of $2.21 million in FY18 as compared to $1.89 million in FY17. On 8 January 2019, the company released a prospectus for private subscription of 1K shares at an issue price of $0.175 per share. On 19 December, the company announced raising a minimum of 6,666,666 new shares via a private placement at 15 cents per share, for working capital requirements.
BBX is poised to the precious metal extraction at Ema and Três Estados, with three exploration licenses across 27,045 hectares for which the Exploration Permit was obtained in March 2018 and Trial Mining License has been submitted. The company is looking forward to the larger-scale pilot plant testing this year followed by commercial-scale production soon.
CCP Technologies Limited (ASX: CT1)
The shares of the IT company, CCP Technologies Limited skyrocketed by 16.67% today, closing the day’s trading session at 1.4 cents as compared to the previous close of 1.2 cents. The company is currently trading with Earnings per share of (0.9) cents. The CT1 stock has offered a negative return of around 63.64% since a year; with share price plunging by 20% this year.
CCP Technologies is a specialist in the Internet of Things (IoT) product development. The company utilizes advanced IoT, Blockchain, Big Data, Machine Learning and AI technology for revolutionizing global food supply chain. Some of its major clients include MGM Grand, Crowne Plaza, Country Valley, Hello Fresh, RACV and many more. As announced on 23 January 2019, CPP has signed an agreement with Eposode Data Solutions for designing and developing a new IoT device for a massive consumer market. The company is projected to obtain $800K per annum in recurring services revenues if Eposode meets their sales forecast. As announced on 21 January 2019, CCP completed the first phase of its hardware development contract with Singapore-based Cre8tec Pte Ltd, by developing new LPWAN movement sensor for pest control.
CCP is poised to establish a strong footprint in the market by expanding fixed location monitoring and contract development services and entering supply chain monitoring, managing cold chain services, and room temperature monitoring.
Lifespot Health Ltd (ASX: LSH)
Healthcare IT company, Lifespot Health Limited noted an impressive gain of 9.64% today, closing the day’s trade at a share price of 9.1 cents with a market capitalization of A$6.44 million. With a negative performance change of 79.25% since its inception, LSH stock has soared by 38.33% this year as on 22 January 2019.
The digital healthcare company is engaged in developing and commercializing medical diagnostic and monitoring technology, allowing patients and healthcare professionals to monitor chronic diseases on their digital devices efficiently. In its Q3FY18 business results, Lifespot stated strong balance sheet with cash of $2.896 million as on 30 September 2018. In December, Lifespot completed the first production of the medical cannabis smart vaporizer with fully integrated Bluetooth connectivity and software ready for user sign-on and automatic integration with the flagship Bodytel platform. Lifespot Health also signed a sales and distribution agreement with CBDS Health, a Canadian cannabis clinical trial company, to use the Seng Vital smart vaporizer system for revolutionizing the R&D clinical trials based on IoMT and big data analytics.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.